You have 9 free searches left this month | for more free features.

palbociclib

Showing 1 - 25 of 156

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Head and Neck Cancer
  • Palbociclib
  • +3 more
  • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
    Samsung Medical Center
Jun 28, 2022

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • +5 more
  • Palbociclib
  • +5 more
  • (no location specified)
Jan 11, 2023

DCIS Trial in Washington (Palbociclib)

Recruiting
  • DCIS
  • Palbociclib
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
Apr 5, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Palbociclib
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 25, 2022

Patterns and Clinical Outcomes of Palbociclib Treated Israel

Completed
  • Metastatic Breast Cancer
  • palbociclib
  • Herzliya Pituach, Israel
    Pfizer Pharmaceuticals Israel Ltd.
Jan 20, 2022

COVID-19 Trial in Brandenburg an der Havel (Palbociclib)

Active, not recruiting
  • COVID-19
  • Palbociclib
  • Brandenburg an der Havel, Germany
    Universitätsklinikum Brandenburg an der Havel
May 11, 2022

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Breast Tumor Female Trial in Melbourne (Venetoclax, Palbociclib, Letrozole)

Recruiting
  • Breast Neoplasm Female
  • Melbourne, Victoria, Australia
  • +2 more
Mar 10, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Palbociclib
  • +3 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +4 more
Jan 10, 2022

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Timisoara, Timi»ô, Romania
    Asociatia Oncohelp - Centrul de Oncologie Oncohelp
Feb 15, 2022

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)

Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Active, not recruiting
  • Tumor, Solid
  • Pancreatic Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Jan 6, 2022

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Palbociclib
  • +7 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 4, 2022

Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)

Recruiting
  • Metastatic Malignant Neoplasm to Brain
  • Palbociclib
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Palbociclib
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Sep 29, 2021